TABLE 1

Clinical characteristics of human subjects

TABLE 1
  • a That is, the number of subjects seroreactive/number of subjects examined. Whole-cell sonicate ELISA was used for Lyme disease subjects, and IgG immunoblotting was used for healthy donors.

  • b Includes four equivocal results.

  • c The remaining patient had facial palsy from Lyme disease.